ASIAN AMERICAN WOMAN WITH BIPOLAR DISORDER

ASIAN AMERICAN WOMAN WITH BIPOLAR DISORDER

2

Decision #1

This decision is designed for start-up medication for patients with bipolar disorder.

Several drugs have been advanced towards solving the medical condition. However, the best

decision is to start Lithium 300mg orally BID.

Reasons for choosing the decision

Normally the patient will not be immediately introduced to a higher amount of

prescriptions of the oral dosages or rather, be subjected to other drugs meant for progressive

medication. Therefore, the reason for this decision is to introduce the patient to Lithium 300mg

that is taken orally on a daily basis. This is where physicians can determine the drug reactions

and the outcome to pick on another decision to work in case this does not materialize.

Anticipated results of the decision

The results I expected were an improvement or rather a slight difference in what was

recorded before the patient started the medication. Perhaps the patient will start experiencing a

state of rest and of course a reduction in her high levels of activeness (Rush, 2017). The oral

dosage of lithium 300gm is a good recommendation for the problem and no doubt I hoped either

two or so problem would be solved with this therapy because this is just a start.

Difference in expected results and the real initial results of the decision

The expectations that there would be some changes did not correspond to the outcome. When the

patient made a visit to the physician after the four weeks of medication, the PNHNP noted that

there were no notable changes at all. The drug had not affected him in any way since the initial